PharmaVOICE: Clinical Leader of Cognizant’s Life Sciences R&D Practice Writes About Transforming Clinical Trial Through Digital Clinical and Code Halos
 |
“Our Code Halos permeate our lives—our work, our families, and our friends—as we have learned everything can be digitized,” writes Larry Florin. “Almost every electronic transaction we conduct forms our individual Code Halos….the life sciences and healthcare industries were reluctant to embark on the transformative activities made possible by the rise of technologies and the Code Halos they enable—what is now the backbone of what we call Digital Clinical.” Excerpts:
“The vast amounts of data available in Code Halos create unlimited potential benefits for Digital Clinical and reshaping life sciences industry processes.
The life sciences arena now understands that these enabling digital technologies are critical to improving clinical trial operational productivity.
An overwhelming majority of life sciences leaders believe that mobile technologies, along with data mining and analytics, have the greatest likelihood to deliver near-term strategic benefits.
Organizations such as TransCelerate Biopharma and the Society for Clinical Research Sites are leading the renewed emphasis to engage more productively with investigators and patients to design trials that satisfy global regulatory requirements, as well as meet payer value and outcome expectations while reducing administrative burden.
More attention is also being paid to patients. From the product development standpoint, patient recruitment and retention remain the top two clinical trial processes severely in need of improvement and optimization. In response, clinical trialists are investing more upfront time designing patient-friendlier studies, collecting information from any number of digitized sources, and using technologies to support patients and keep them interested and compliant, respectively. Likewise, online Digital Clinical patient recruitment approaches—such as social media, advertising, patient advocacy and more precise EHR data mining techniques—are being adopted that complement, but do not supplant, conventional media and direct mail outreach.
Another ongoing Digital Clinical revolution is the rapidly accelerating adoption of mobile, self-serve diagnostic, monitoring, and treatment modalities (mHealth) in both the healthcare and clinical trial arenas.
Taken a bit further, digital technology makes it possible to continuously monitor, in real-time, the well-being of patients during and after clinical trials to collect data and insights into patient health and compliance, as well as the safety and effectiveness of the therapy.
As the data volumes in our Code Halos expand, so do clinical trial databases; therefore, we need to be able to intelligently harness and make sense of the data in order to make informed, timely, actionable decisions.
Life sciences companies are witnessing a wholesale transformation of the clinical trial operational delivery model driven by ever improving digital clinical technology tools. Correspondingly, these tools are expected to improve trial design, yield higher quality data at lower cost and, ideally, accelerate product development cycle times, permitting the faster release of new products to help patients.”
Click below to read the article.
